• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - disease models
Tag:

disease models

Health

Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential

by Chief Editor February 21, 2026
written by Chief Editor

Beyond Veklury: The Evolution of Antiviral Strategies for COVID-19 and Future Pandemics

In October 2020, the FDA approved Veklury (remdesivir) as the first treatment for COVID-19, marking a significant milestone in the fight against the pandemic. However, initial enthusiasm surrounding remdesivir’s efficacy, demonstrated in cell cultures, didn’t fully translate to clinical outcomes in humans. Reports indicated its effectiveness was below 10%, largely attributed to its instability in the presence of plasma.

The Challenge of Drug Stability and Bioavailability

The story of remdesivir highlights a critical challenge in antiviral drug development: ensuring stability, and bioavailability. Many promising compounds falter not because of a lack of inherent antiviral activity, but because they degrade before reaching their target within the body. This degradation can be caused by enzymes, pH levels, or, as seen with remdesivir, the components of blood plasma.

Remdesivir Bis-Propionate: A Pro-Drug Approach

Researchers have been exploring strategies to overcome this hurdle. One approach involves creating pro-drugs – modified versions of existing drugs that are more stable and better absorbed. Remdesivir bis-propionate (remdesivir-bP) represents one such effort. Studies suggest remdesivir-bP exhibits improved in vivo stability compared to remdesivir alone. In other words it lasts longer in the body, potentially increasing its effectiveness.

Biopolymer Encapsulation: A Protective Shield

Another innovative strategy focuses on protecting the drug itself. Encapsulating remdesivir within a biopolymer, like NV387, acts as a shield, preventing degradation in the plasma. Combining both approaches – a pro-drug form and encapsulation – appears to yield the most promising results. Research indicates that remdesivir-bP encapsulated within NV387 demonstrates the highest antiviral activity against NL-63 infection in rat models, surpassing both naked remdesivir and remdesivir-bP alone.

The Efficacy Hierarchy: A Mathematical Perspective

The observed improvements can be summarized as follows: remdesivir-bP-encapsulated > remdesivir-encapsulated > remdesivir-bP > remdesivir. This demonstrates a clear progression in antiviral efficacy achieved through targeted modifications and delivery systems.

Implications for Future Pandemic Preparedness

These advancements extend beyond COVID-19. The lessons learned from remdesivir’s development and subsequent refinement are directly applicable to preparing for future pandemics. Focusing on drug stability and bioavailability early in the development process can significantly increase the chances of success. The use of pro-drugs and encapsulation technologies offers a powerful toolkit for enhancing the effectiveness of antiviral therapies.

Beyond SARS-CoV-2: Broad-Spectrum Antiviral Development

The principles applied to remdesivir can be adapted to develop broad-spectrum antivirals – drugs effective against a wide range of viruses. This is particularly crucial given the unpredictable nature of emerging infectious diseases. Investing in research focused on these core technologies could provide a critical defense against future outbreaks.

Did you know? Remdesivir is an antiviral drug with activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

FAQ

Q: What is a pro-drug?
A: A pro-drug is an inactive or less active form of a drug that is converted into its active form within the body.

Q: What is biopolymer encapsulation?
A: Biopolymer encapsulation involves surrounding a drug with a protective layer made of a naturally occurring polymer, shielding it from degradation.

Q: Why was the initial efficacy of remdesivir lower than expected?
A: Remdesivir’s instability in the presence of plasma contributed to its lower-than-expected efficacy in human trials.

Q: Is remdesivir still used to treat COVID-19?
A: The FDA approved remdesivir for the treatment of COVID-19 requiring hospitalization in 2020. Further research continues to refine its use and explore improved formulations.

Pro Tip: Understanding the pharmacokinetic properties of a drug – how the body absorbs, distributes, metabolizes, and excretes it – is essential for optimizing its effectiveness.

Want to learn more about antiviral drug development and pandemic preparedness? Explore our other articles on emerging infectious diseases and pharmaceutical innovation. Subscribe to our newsletter for the latest updates and insights.

February 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Vitamin D alleviates obesity-related metabolic abnormalities by modulating the gut microbiota in older female mice on a high-fat diet

by Chief Editor December 27, 2025
written by Chief Editor

The Gut-Brain-Estrogen Connection: How Vitamin D Could Redefine Women’s Health

As women age, the decline in estrogen isn’t just about menopause. It’s a systemic shift impacting everything from lipid metabolism and weight management to cardiovascular health. Emerging research, however, points to a surprising ally in mitigating these effects: vitamin D, and its profound influence on the gut microbiome. This isn’t just about supplementation; it’s about understanding a complex interplay that could revolutionize preventative healthcare for older women.

The Estrogen-Microbiome Link: A Delicate Balance

Estrogen profoundly influences the composition of the gut microbiome. Studies show estrogen can increase the diversity of beneficial bacteria, particularly those involved in short-chain fatty acid (SCFA) production. SCFAs, like butyrate, are crucial for gut health, reducing inflammation, and even impacting brain function. When estrogen levels decline, this microbial balance shifts, often leading to dysbiosis – an imbalance associated with obesity, insulin resistance, and increased risk of chronic diseases. A 2022 study in Cell Host & Microbe highlighted this connection, emphasizing the need to consider the microbiome when addressing age-related hormonal changes.

Pro Tip: Focus on prebiotic-rich foods like onions, garlic, leeks, and asparagus to nourish beneficial gut bacteria. These act as food for the microbes, promoting a healthier gut environment.

Vitamin D: More Than Just Bone Health

For years, vitamin D’s primary role was understood to be calcium absorption and bone health. However, its influence extends far beyond. Vitamin D receptors (VDRs) are present not only in bone cells but also in immune cells, brain cells, and – crucially – in the gut. Vitamin D modulates the gut barrier function, strengthening the intestinal lining and preventing “leaky gut,” a condition where bacteria and toxins escape into the bloodstream, triggering inflammation. Recent research, including a 2025 study published in Frontiers in Cellular and Infection Microbiology, suggests vitamin D can directly impact lipid metabolism by influencing gut microbial composition.

The Emerging Role of Gut Microbiota Modulation

The key finding from the Frontiers in Cellular and Infection Microbiology study is that vitamin D supplementation in older female mice altered the gut microbiome, increasing the abundance of beneficial bacteria like Bacteroides and Faecalibaculum, while reducing potentially harmful species. This shift correlated with improved lipid profiles, reduced inflammation, and enhanced intestinal barrier integrity. This suggests a potential pathway for preventing or mitigating metabolic abnormalities associated with estrogen decline.

Did you know? Approximately 50% of the population is estimated to be vitamin D deficient, increasing the risk of various health issues, including gut dysbiosis.

Future Trends: Personalized Microbiome-Based Interventions

The future of women’s health lies in personalized interventions. Instead of a one-size-fits-all approach, we’re moving towards tailoring treatments based on an individual’s unique microbiome profile. This includes:

  • Microbiome Testing: Routine gut microbiome analysis to identify imbalances and guide targeted interventions.
  • Precision Probiotics: Probiotic formulations designed to address specific microbial deficiencies identified through testing.
  • Personalized Diet Plans: Dietary recommendations based on an individual’s microbiome composition and estrogen levels.
  • Vitamin D Optimization: Determining optimal vitamin D levels through blood testing and adjusting supplementation accordingly.
  • Fecal Microbiota Transplantation (FMT): While still in its early stages, FMT holds promise for restoring a healthy gut microbiome in severe cases of dysbiosis.

The Role of Artificial Intelligence (AI) in Gut Health

AI and machine learning are poised to play a significant role in analyzing complex microbiome data. AI algorithms can identify patterns and correlations that humans might miss, leading to more accurate diagnoses and personalized treatment plans. Companies like Viome are already utilizing AI to analyze gut microbiome data and provide personalized nutrition recommendations.

Addressing the Challenges

Despite the promising research, several challenges remain. Standardizing microbiome testing, understanding the long-term effects of interventions, and addressing the cost and accessibility of personalized treatments are crucial steps. Furthermore, more research is needed to confirm these findings in human populations and to determine the optimal dosage and form of vitamin D for maximizing gut health benefits.

FAQ

  • Q: What is the best way to improve my gut health?
    A: Focus on a diverse diet rich in fiber, prebiotics, and probiotics. Consider getting your vitamin D levels checked and supplementing if necessary.
  • Q: Can vitamin D supplements really make a difference?
    A: Yes, but it’s important to get your levels tested and work with a healthcare professional to determine the appropriate dosage.
  • Q: Is gut microbiome testing accurate?
    A: Accuracy varies depending on the testing method. Choose a reputable lab and discuss the results with a qualified healthcare provider.
  • Q: What are SCFAs and why are they important?
    A: Short-chain fatty acids are produced by gut bacteria when they ferment fiber. They provide energy for gut cells, reduce inflammation, and have systemic health benefits.

The connection between estrogen, the gut microbiome, and vitamin D is a rapidly evolving field. By embracing a holistic approach that considers these interconnected factors, we can pave the way for a healthier future for women of all ages.

Want to learn more? Explore our articles on hormone balance and the power of probiotics. Share your thoughts and experiences in the comments below!

December 27, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Engineered Adipocytes Target Tumor Growth in Cancer Models

by Chief Editor February 6, 2025
written by Chief Editor

The Future of Cancer Treatment: Adipose Manipulation and Cellular Therapy

Researchers at the University of California, San Francisco (UCSF) have pioneered a groundbreaking approach that could revolutionize cancer treatment. By converting white fat cells into “beige” fat cells and implanting them in cancer models, they’ve demonstrated a potential new strategy to starve tumors of crucial nutrients.

How Beige Fat Cells Outcompete Cancer

Unlike white fat, beige fat cells can be activated to consume large amounts of glucose and fatty acids, effectively depriving tumors of the nutrition they need to thrive. This innovation, known as adipose manipulation transplantation (AMT), uses the CRISPR gene-editing technology to enhance this effect.

In lab experiments, these modified beige fat cells were shown to significantly suppress cancer progression when implanted alongside cancer cells in mice. UCSF scientists observed reduced growth, angiogenesis, and hypoxia in several types of cancer, including breast, pancreatic, and prostate.

Real-Life Potential and Personalization

UCSF’s findings pave the way for personalized cancer treatments, where a patient’s own fat cells could be engineered to combat their specific type of cancer. Jennifer Rosenbluth, MD, PhD, a breast cancer specialist at UCSF, has been instrumental in testing this personalized approach using breast cancer mastectomy samples.

This advancement suggests that in the near future, modifying a patient’s fat cells to outcompete their unique cancer type at the dietary level could become a viable treatment option.

Advantages Over Traditional Therapies

One of the key benefits of using engineered fat cells for therapy is their adaptability. They can be programmed to consume specific nutrients cancer cells prefer, or even emit beneficial signals and manage sugar levels. With fewer risks of cells migrating unpredictably, they offer a safer alternative to some current treatments.

As Ahituv, the study’s senior author, noted, fat cells have the potential to be tailored for a wide range of diseases, not limited to cancer. The technology exemplifies how fat, often overlooked, can serve as a powerful therapy tool.

Looking Ahead: Evergreen Opportunities

This research is just the beginning of unlocking the therapeutic potentials of adipose cells. Future studies will likely explore further applications, including treatments for diabetes and conditions like hemochromatosis.

Frequently Asked Questions

  • Can this technique be used for all types of cancer?
    No, it must first be tailored to each cancer’s specific nutrient dependencies, but the approach shows promise across various types.
  • Is this treatment already available to patients?
    Currently, it is still in research phases, but ongoing trials could lead to human applications in the future.
  • What are the potential side effects?
    More research is needed, but engineered fat cells are considered safe as they are derived from a patient’s own body.

Did you know? Cold therapy, which activates brown fat to suppress cancer in mice, inspired this research despite being impractical for patients with fragile health.

Pro Tip: Staying informed on clinical trials and advances in personalized medicine can provide opportunities to participate in future therapies emerging from research like UCSF’s.

Take Action: Connect with the Future of Medicine

Are you intrigued by the potential of cell-based therapies? Explore more articles on our website about cutting-edge medical research. Stay informed and subscribe to our newsletter for the latest in health and scientific breakthroughs.

February 6, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Tennis Star Mums Celebrate Mother’s Day

    April 23, 2026
  • Ratings slump as Kyle and Jackie O sued for millions

    April 23, 2026
  • Man dies after calling GP three times failed to get him the ‘urgent help’ he needed

    April 23, 2026
  • Search Legal Listings in Italy

    April 23, 2026
  • Creating Realistic Open-World Environments in Video Games

    April 23, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World